Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Pain · Hyponatremia · CPIX

Cumberland Pharmaceuticals

CUMBERLAND PHARMACEUTICALS INC

Cumberland Pharmaceuticals patent portfolio — 34 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
1600 W End Ave, #1300, Nashville, Tennessee 37203, US HQ
1999 Founded
128 Employees
Public company Type
CPIX · NYSE Ticker
Company details
Status
Public
HQ
1600 W End Ave, #1300, Nashville, Tennessee 37203, US
Founded
1999
Employees
128
Programs
53
Drugs
26
Patents
34
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Cumberland Pharmaceuticals patents

34 pharmaceutical patents indexed for Cumberland Pharmaceuticals. 0 expire within 24 months.

Cumberland Pharmaceuticals has 34 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

34 patents

Patent portfolio

  1. US 12161632

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11806400

    Injectable ibuprofen formulation

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11571412

    Thromboxane receptor antagonists in AERD/asthma

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10925860

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10751383

    Doses and methods for administering telavancin

    Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10583126

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10456380

    Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10314824

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10064845

    Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10016399

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9931311

    Treating critically ill patients with intravenous ibuprofen

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9820966

    Stabilized statin formulations

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9693998

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9649284

    Treating critically ill patients with intravenous ibuprofen

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9375441

    Lactulose for bowel evacuation

    Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9327028

    Acetylcysteine compositions and methods of use thereof

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9295639

    Treating critically ill patients with intravenous ibuprofen

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9138404

    Treating critically ill patients with intravenous ibuprofen

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9114068

    Treating patients with intravenous ibuprofen

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9072661

    Injectable ibuprofen formulation

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9072710

    Injectable ibuprofen formulation

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9012508

    Administration of intravenous ibuprofen

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8952065

    Acetylcysteine composition and uses thereof

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8933115

    Stabilized statin formulations

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8871810

    Treating critically ill patients with intravenous ibuprofen

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8778907

    Lactulose for bowel evacuation

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8735452

    Treating patients with intravenous ibuprofen

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8722738

    Acetycysteine compositions and methods of use thereof

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8653061

    Acetylcysteine composition and uses thereof

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8399445

    Acetylcysteine composition and uses thereof

    Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8372877

    Stabilized statin formulations

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8148356

    Acetylcysteine composition and uses therefor

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 6727286

    Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid

    Expires Mon Apr 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6514537

    Magnesium citrate solution

    Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Cumberland Pharmaceuticals have?

34 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Cumberland Pharmaceuticals patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.